Ultra-early response assessment in lymphoma treatment: [(18)F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment

PURPOSE: To determine whether, in patients with Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL), [(18)F]FDG PET/MR can capture treatment effects within the first week after treatment initiation, and whether changes in glucose metabolism and cell density occur simultaneously. METHODS: Patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayerhoefer, Marius E., Raderer, Markus, Jaeger, Ulrich, Staber, Philipp, Kiesewetter, Barbara, Senn, Daniela, Gallagher, Ferdia A., Brindle, Kevin, Porpaczy, Edit, Weber, Michael, Berzaczy, Dominik, Simonitsch-Klupp, Ingrid, Sillaber, Christian, Skrabs, Cathrin, Haug, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915494/
https://www.ncbi.nlm.nih.gov/pubmed/29480328
http://dx.doi.org/10.1007/s00259-018-3937-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915494/
https://www.ncbi.nlm.nih.gov/pubmed/29480328
http://dx.doi.org/10.1007/s00259-018-3937-z

Ejemplares similares